About Keystone Heart
Keystone Heart is a company based in Tampa (United States) founded in 2004 was acquired by Venus MedTech in September 2018. Keystone Heart has raised $14 million across 1 funding round from investors including Venus MedTech and Orbimed. Keystone Heart operates in a competitive market with competitors including Claret Medical, Emboline, Protembis, Synaptive Medical and Filterlex Medical, among others.
- Headquarter Tampa, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14 M (USD)
in 1 rounds
-
Latest Funding Round
$14 M (USD), Series B
May 01, 2014
-
Investors
Venus MedTech
& 1 more
-
Employee Count
Not available
-
Acquired by
Venus MedTech
(Sep 25, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Keystone Heart
Keystone Heart has successfully raised a total of $14M through 1 strategic funding round. The most recent funding activity was a Series B round of $14 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Keystone Heart
Keystone Heart has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Venus MedTech and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
Locked | Locked | Locked |
Investor details for Keystone Heart
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Keystone Heart
Investment portfolio details for Keystone Heart
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Keystone Heart
Detailed financials for Keystone Heart
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Keystone Heart Comparisons
Peer comparison for Keystone Heart
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Keystone Heart
Keystone Heart operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Claret Medical, Emboline, Protembis, Synaptive Medical and Filterlex Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cerebral vascular protection systems for endovascular procedures are developed.
|
|
| Locked | Locked | Locked |
Aortic embolic protection devices are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Manufacturer of cerebral protection device
|
|
| Locked | Locked | Locked |
Planning and imaging solutions for neurosurgery are developed.
|
|
| Locked | Locked | Locked |
Developer of an embolic protection device
|
Detailed competitors of Keystone Heart
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Keystone Heart
Complete news archive for Keystone Heart
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Keystone Heart
Keystone Heart was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Keystone Heart is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Keystone Heart is a funded company, having raised a total of $14M across 1 funding round to date.
Keystone Heart produces TriGuard, embolic cerebral protection devices to decrease the risk of stroke, neurocognitive decline and dementia caused by brain emboli during cardiovascular procedures such as Surgical valve replacement, Ablation for Atrial fibrillation, TAVR etc... The TriGuard device uses a self deploying and self positioning Nitinol frame and mesh to provide coverage to all three major blood vessels arising from the Aortic arch. TriGuard is not commercially available in USA as of June 2016.
Keystone Heart's top competitors include Protembis, Synaptive Medical and Emboline.
Keystone Heart has 2 investors. Key investors include Venus MedTech, and Orbimed.